I agree that this site is using cookies. You can find further informations here.
X
Barlesi, F.
220  results:
Search for persons X
?
1

193O Long-term outcomes after concurrent once- or twice-dai..:

Walls, G. ; Mistry, H. ; Barlesi, F....
ESMO Open.  9 (2024)  - p. 102766 , 2024
Link: https://doi.org/10.1016/..
 
?
2

242P Prognostic role of tumor microenvironment features in ..:

Zullo, L. ; Marinello, A. ; Ghigna, M.R....
ESMO Open.  9 (2024)  - p. 102892 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Immune checkpoint blockers in solid organ transplant recipi..:

Remon, J. ; Auclin, E. ; Zubiri, L....
ESMO Open.  9 (2024)  5 - p. 103004 , 2024
Link: https://doi.org/10.1016/..
 
?
4

103TiP Sotorasib versus pembrolizumab in combination with p..:

Barlesi, F. ; Felip, E. ; Popat, S....
ESMO Open.  9 (2024)  - p. 102682 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Recommendations for the use of next-generation sequencing (..:

Mosele, M.F. ; Westphalen, C.B. ; Stenzinger, A....
Annals of Oncology.  35 (2024)  7 - p. 588-606 , 2024
Link: https://doi.org/10.1016/..
 
?
6

EP11.03-28 Real World Outcomes after Chemotherapy and Immun..:

Leal, T. ; Dasgupta, A. ; Latremouille-Viau, D....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S632 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P2.07-05 Immune Checkpoint Blockers in Lung Cancer after So..:

Remon Masip, J. ; Auclin, E. ; Aboubakar Nana, F....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S325 , 2023
Link: https://doi.org/10.1016/..
 
?
8

80P Tumor microenvironment (TME) defines prognosis of EGFR-..:

Zullo, L. ; Ghigna, M.R. ; Zrafi, W.S....
ESMO Open.  8 (2023)  1 - p. 101890 , 2023
Link: https://doi.org/10.1016/..
 
?
9

5O Deciphering resistance mechanisms in cancer: Insights fr..:

Beshiri, K. ; Vasseur, D. ; Bigot, L....
ESMO Open.  8 (2023)  1 - p. 101651 , 2023
Link: https://doi.org/10.1016/..
 
?
10

78P Final analysis of the French real-world study EVIDENS: ..:

Barlesi, F. ; Dixmier, A. ; Debieuvre, D....
Immuno-Oncology and Technology.  20 (2023)  - p. 100550 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Anti-TIGIT therapies for solid tumors: a systematic review:

Rousseau, A. ; Parisi, C. ; Barlesi, F.
ESMO Open.  8 (2023)  2 - p. 101184 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P1.22-20 High Incidence of Ischemic Stroke in Patients with..:

Aldea, M. ; Marinello, A. ; Guyon, D....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S254 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Harnessing tumor immunity with cytotoxics: T cells monitori..:

Sicard, G. ; Protzenko, D. ; Giacometti, S....
British Journal of Cancer.  129 (2023)  9 - p. 1373-1382 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Inequality factors in access to early-phase clinical trials..:

Charton, E. ; Baldini, C. ; Fayet, Y....
ESMO Open.  8 (2023)  4 - p. 101610 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P1.23-07 Clinical Impact of Clonal Hematopoiesis in Patient..:

Tagliamento, M. ; Marzac, C. ; Aldea, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S258 , 2023
Link: https://doi.org/10.1016/..
 
1-15